Perinatal outcome of infants exposed to cocaine and/or heroin in utero

R. Fulroth, B. Phillips and D. J. Durand
Department of Pediatrics, Highland General Hospital, Oakland, Calif.

While cocaine is now used much more frequently than heroin by women of childbearing age, we have found that a significant number of mothers have abused both drugs during their pregnancy. We studied 86 infants who were born to women with a history of cocaine and/or heroin use during pregnancy. The newborns were observed over a 5-day hospital period using a standardized abstinence scoring system and urine drug screening of both mother and infant. Of these, 35 had maternal and/or newborn urine test results that were positive for cocaine only (cocaine group), 14 that were positive for heroin only (heroin group), 17 that were positive for both cocaine and heroin (cocaine/heroin group), and 20 that were negative for both, although the mothers admitted to cocaine use during their pregnancy (cocaine history group). In approximately half of the mother/infant pairs, the results of the urine drug tests were discordant. Microcephaly and growth retardation occurred most frequently in the infants in the cocaine group (17% and 27%, respectively). Microcephaly was also found to be significant in the infants in the cocaine/heroin group. Signs of drug withdrawal occurred in all four drug-exposed groups. Mild withdrawal occurred in 26% of infants in the cocaine group, 21% of the infants in the heroin group, 47% of the infants in the cocaine/heroin group, and in 30% of the infants in the cocaine history group. Withdrawal requiring treatment occurred in 6% of the infants in the cocaine group, 14% of the infants in the heroin group, 35% of infants in the cocaine/heroin group, and 5% of the infants in the cocaine history group. The use of heroin with cocaine has a synergistic effect on the behavior of the newborn.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Seizures and substance abuse: Treatment considerations
Brust
Neurology 2006;67:S45-S48.
ABSTRACT | FULL TEXT  

Treatment of neonatal abstinence syndrome
Johnson et al.
Arch. Dis. Child. Fetal Neonatal Ed. 2003;88:F2-5.
ABSTRACT | FULL TEXT  

Central and autonomic system signs with in utero drug exposure
Bada et al.
Arch. Dis. Child. Fetal Neonatal Ed. 2002;87:F106-112.
ABSTRACT | FULL TEXT  

The Search for Congenital Malformations in Newborns With Fetal Cocaine Exposure
Behnke et al.
Pediatrics 2001;107:74e-74.
ABSTRACT | FULL TEXT  

Hyperphagia in neonates withdrawing from methadone
Martinez et al.
Arch. Dis. Child. Fetal Neonatal Ed. 1999;80:178F-182.
ABSTRACT | FULL TEXT  

Incidence of Passive Exposure to Crack/Cocaine and Clinical Findings in Infants Seen in an Outpatient Service
Lustbader et al.
Pediatrics 1998;102:5e-5.
ABSTRACT | FULL TEXT  

Neonatal Drug Withdrawal.
Committee on Drugs
Pediatrics 1998;101:1079-1079.
ABSTRACT | FULL TEXT  

Birth Outcome From a Prospective, Matched Study of Prenatal Crack/Cocaine Use: I. Interactive and Dose Effects on Health and Growth
Eyler et al.
Pediatrics 1998;101:229-236.
ABSTRACT | FULL TEXT  

Mortality Within the First 2 Years in Infants Exposed to Cocaine, Opiate, or Cannabinoid During Gestation
Ostrea Jr et al.
Pediatrics 1997;100:79-83.
ABSTRACT | FULL TEXT  

Detection of intrauterine illicit drug exposure by newborn drug testing
Kwong and Ryan
Clin. Chem. 1997;43:235-242.
ABSTRACT | FULL TEXT  

Utility of Laboratory Screening in Cocaine-Exposed Infants
Beltran et al.
CLIN PEDIATR 1994;33:683-685.
 

Subcutaneous Fat Necrosis of the Newborn: Link to Maternal Use of Cocaine During Pregnancy
Carraccio et al.
CLIN PEDIATR 1994;33:317-318.
ABSTRACT